Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.49 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29627490 | 1.00 | MEN1 (0.61) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL1763611 | 0.92 | MEN1 (0.58) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL29938229 | 0.92 | MEN1 (0.58) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL13596619 | 0.89 | SMN1; SMN2 (0.58) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL1763613 | 0.89 | MEN1 (0.55) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL23870561 | 0.89 | MEN1 (0.55) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL31676628 | 0.89 | SMN1; SMN2 (0.58) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL6849222 | 0.88 | MEN1 (0.71) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL4988971 | 0.85 | SMN1; SMN2 (0.61) | MEN1KMT2AALDH1A1GAAPKM | |
| SCHEMBL70296 | 0.85 | MEN1 (0.58) | MEN1KMT2AALDH1A1GAAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4634 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110621673-A | Double-stranded linked cytotoxic drug conjugates | 杭州多禧生物科技有限公司 | 2019-12-27 | — | — | CN | claimed |
| EP-2648510-B1 | METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERS | IMMUNOGEN INC (US) | 2016-08-31 | — | — | EP | claimed |
| US-9242936-B2 | Methods for the preparation of charged crosslinkers | IMMUNOGEN, INC. (US) | 2016-01-26 | — | — | US | claimed |
| US-20150166482-A1 | METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERS | IMMUNOGEN, INC. | 2015-06-18 | — | — | US | claimed |
| US-8754039-B2 | Targeted antimicrobial moieties | C3 JIAN, INC. (US) | 2014-06-17 | — | — | US | claimed |
| US-8598362-B2 | Methods for the preparation of charged crosslinkers | IMMUNOGEN, INC. (US) | 2013-12-03 | — | — | US | claimed |
| EP-2648510-A1 | METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERS | ImmunoGen, Inc. (US) | 2013-10-16 | — | — | EP | claimed |
| US-20120165537-A1 | METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERS | IMMUNOGEN, INC. (US) | 2012-06-28 | — | — | US | claimed |
| WO-2012078868-A1 | METHODS FOR THE PREPARATION OF CHARGED CROSSLINKERS | IMMUNOGEN, INC. (US) | 2012-06-14 | — | — | WO | claimed |
| US-RE35524-E | Epipodophyllotoxin glucoside 4'-phosphate derivatives | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-06-03 | — | — | US | claimed |
| US-4904768-A | Epipodophyllotoxin glucoside 4'-phosphate derivatives | BRISTOL-MYERS COMPANY (US) | 1990-02-27 | — | — | US | claimed |
| EP-3620473-B1 | NOVEL HETERODIMERIC PROTEINS | XENCOR INC (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4748862-A2 | HETERODIMERIC PROTEINS | Xencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3865514-B9 | BISPECIFIC ANTIBODY BINDING DLL3 AND CD3 | AMGEN RES MUNICH GMBH (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-12630650-B2 | Engineered IgA antibodies and methods of use | TIGATX, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| WO-1989012678-A1 | PURIFIED UBIQUITIN HYDROLASE, DNA SEQUENCES ENCODING SAME, AND ITS USE IN RECOVERING POLYPEPTIDES | GENENTECH, INC. (US) | 1989-12-28 | — | — | WO | disclosed |
| EP-0339695-A2 | A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 1989-11-02 | — | — | EP | disclosed |
| WO-1988009376-A1 | METHOD AND COMPOSITIONS FOR MAKING ACSF AND ACSF ANTAGONISTS | GENENTECH, INC. (US) | 1988-12-01 | — | — | WO | disclosed |
| US-4406885-A | Preparation of native oncornavirus envelope subunits and vaccines therefrom | RESEARCH CORPORATION (US) | 1983-09-27 | — | — | US | disclosed |
| US-4009168-A | STABILIZERS FOR POLYOLEFINS | UBE INDUSTRIES, LTD. (JA) | 1977-02-22 | — | — | US | disclosed |